The Best Fidelity Funds to Invest in after the Fed Meeting

The Federal Reserve said in a statement today that it will wind down its bond purchasing program in October, but will continue to aim at keeping interest rates low for a considerable time. Initially, equity markets reacted positively to the news, but the rally faded by the close of the market session.

From the technical standpoint, the most interesting development was the Dow Jones Industrial Average hitting a new all-time high at 17,156, while the other major indexes were not able to follow through. Small cap stocks, which typically lead the market in the early phases of a growth cycle, are the weakest right now.

As money rotates into large-cap blue chip stocks, the Fidelity Large Cap Growth Enhanced Index Fund (FLGEX) may be one of the best ways to put fresh money to work in the current market environment:



Unlike what we have seen during previous market rallies earlier this year, not all sectors show positive momentum right now. Consequently, as we head into the seasonally weak October period, investors will have to be increasingly more selective. The technology and health care sectors show the strongest relative strength right now and barely corrected during the recent sell off. Here are two Fidelity funds that investors can consider using to overweight positions in these two large sectors:




While the Fed’s intention is to keep interest rates low, the yield on the long-term Treasury bond has started rising already and broke its long-term trend today:



As the result, the bond market sold off and most Fidelity bond funds retreated, as well. Should interest rates continue to climb, bond fund investors will be faced with a difficult situation: the Net Asset Value (price) of their funds can decrease, while they will still be liable for paying taxes on the dividends distributed by the funds. This situation may force more selling of bond funds, which can create a negative feedback cycle for the bond market. The trend reversal for the following two widely held Fidelity bond funds show the potential danger bond investors will face in a rising interest rate environment:





Buy and sell signals for Fidelity funds are available at


Two Investment Strategies that can Help you to Take Advantage of Declining Interest Rates

Already low interest rates have prompted many market observers to call for the decline of interest rate sensitive investments when the New Year started in January, but the opposite happened. Long-term treasury yields dropped and continue to decline:


As Treasury bond yields declined and the economy showed signs of improvement, investors have started to seek out high-yielding corporate bonds. The Fidelity Capital and Income Fund (FAGIX) is an excellent way to participate in this trend:


Emerging market economies are known to experience cycles of boom and bust. The boom periods can be highly rewarding for investors by producing double or sometimes even triple digit gains, while the bust periods tend to make risk averse investors exit these markets and seek out low-risk investments.

Declining interest rates, market friendly Fed policies, slow and steady economic growth, increased risk tolerance by investors and renewed appetite for investments with outsized returns have created a new bull market in emerging market equities in late spring. Our favorite fund in this space is the Fidelity Emerging Markets Fund (FEMKX), which have produced stellar returns since its inception in 1990.


Buy and sell signals for Fidelity funds are available at


Market Correction: Treasury Bond Fund is Trending Higher; Biotechnology Sector is at Oversold Levels and May See a Bounce Next Week

We noted in in the March 26 blog article that the sector rotation has intensified as we approach the seasonally weak April-May period. In the last two weeks the stock market sell off continued, which negatively impacted most equity mutual funds.

Long-term interest rates have also started to decline, which benefits the Fidelity Spartan Long-Term Treasury Bond Fund (FLBIX). The chart below shows the inverse correlation of FLBIX and interest rates (see $TYX, the 30-year Treasury Bond Yield Index on the top panel).


The biotechnology sector corrected the hardest in recent weeks. However, technical indicators show now that we have reached an oversold condition and a bounce is likely in the coming week: